Statement re Offer for Subscription

RNS Number : 3062O
Maven Income & Growth VCT PLC
08 February 2021
 

Maven Income and Growth VCT PLC (the Company)

 

Offer for Subscription

 

8 February 2021

 

On 23 October 2020, the Company and Maven Income and Growth VCT 5 PLC announced the publication of a joint Prospectus (comprising a Securities Note, Registration Document and Summary) in relation to offers for subscription of new Ordinary Shares of 10p each (together the "Offers" and each an "Offer").

 

The Board is pleased to advise that, with valid subscriptions received to date under the Company's Offer now approaching its initial fundraising target of £10 million, and in view of continued interest from potential investors, the Directors have resolved to utilise the over-allotment facility, as provided for under the terms and conditions of the Offers, to the extent required to meet further investor demand.

 

The deadline for receipt of applications for the Offers is 12.00 noon on 30 March 2021 in relation to the tax year 2020/21 and 12.00 noon on 30 April 2021 in relation to the tax year 2021/22. The Offers will close on 4 May 2021 unless the relevant Offer is fully subscribed by an earlier date or extended by the relevant Board to no later than 6 October 2021.

 

Downloadable versions of the Prospectus documents are available at: www.mavencp.com/vctoffer .

 

Any enquiries in respect of the Offers, or requests for copies of the Prospectus documents (available free of charge), should be directed to:

 

Maven Capital Partners UK LLP

Kintyre House

205 West George Street

Glasgow

G2 2LW

 

Telephone: 0141 306 7400

E-mail: enquiries@mavencp.com  

Maven Capital Partners UK LLP
Secretary

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STRKVLBBFLLEBBX
UK 100

Latest directors dealings